BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Landis-Piwowar K, Chen D, Foldes R, Chan TH, Dou QP. Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 - present). Expert Opin Ther Pat 2013;23:189-202. [PMID: 23230990 DOI: 10.1517/13543776.2013.743993] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Liu L, Ma H. Label-free real-time investigation of the effect of telomerase inhibitors based on quartz crystal microbalance measurement. Sensors and Actuators B: Chemical 2017;239:943-50. [DOI: 10.1016/j.snb.2016.08.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
2 Xifró X, Vidal-Sancho L, Boadas-Vaello P, Turrado C, Alberch J, Puig T, Verdú E. Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice. PLoS One 2015;10:e0123122. [PMID: 25855977 DOI: 10.1371/journal.pone.0123122] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
3 Kumar AS, Shanmugam R, Nellaiappan S, Thangaraj R. Tea quality assessment by analyzing key polyphenolic functional groups using flow injection analysis coupled with a dual electrochemical detector. Sensors and Actuators B: Chemical 2016;227:352-61. [DOI: 10.1016/j.snb.2015.12.072] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
4 Kuo CL, Chen TS, Liou SY, Hsieh CC. Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model. Immunopharmacol Immunotoxicol 2014;36:364-70. [PMID: 25151997 DOI: 10.3109/08923973.2014.953637] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
5 Castro Nava A, Cojoc M, Peitzsch C, Cirillo G, Kurth I, Fuessel S, Erdmann K, Kunhardt D, Vittorio O, Hampel S, Dubrovska A. Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids: Development of Novel Radiochemotherapy. Int J Cancer 2015;137:2492-503. [DOI: 10.1002/ijc.29614] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
6 Yahfoufi N, Alsadi N, Jambi M, Matar C. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients 2018;10:E1618. [PMID: 30400131 DOI: 10.3390/nu10111618] [Cited by in Crossref: 321] [Cited by in F6Publishing: 267] [Article Influence: 80.3] [Reference Citation Analysis]
7 Jin J, Liu C, Tong H, Sun Y, Huang M, Ren G, Xie H. Encapsulation of EGCG by Zein-Gum Arabic Complex Nanoparticles and In Vitro Simulated Digestion of Complex Nanoparticles. Foods 2022;11:2131. [DOI: 10.3390/foods11142131] [Reference Citation Analysis]
8 Martinotti S, Ranzato E, Burlando B. (-)- Epigallocatechin-3-gallate induces GRP78 accumulation in the ER and shifts mesothelioma constitutive UPR into proapoptotic ER stress. J Cell Physiol 2018;233:7082-90. [PMID: 29744892 DOI: 10.1002/jcp.26631] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
9 Sahadevan R, Singh S, Binoy A, Sadhukhan S. Chemico-biological aspects of (-)-epigallocatechin-3-gallate (EGCG) to improve its stability, bioavailability and membrane permeability: Current status and future prospects. Crit Rev Food Sci Nutr 2022;:1-30. [PMID: 35491671 DOI: 10.1080/10408398.2022.2068500] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Samutprasert P, Chiablaem K, Teeraseranee C, Phaiyarin P, Pukfukdee P, Pienpinijtham P, Svasti J, Palaga T, Lirdprapamongkol K, Wanichwecharungruang S. Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells. RSC Adv 2018;8:7369-76. [DOI: 10.1039/c7ra10997k] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Natalucci V, Virgili E, Calcagnoli F, Valli G, Agostini D, Zeppa SD, Barbieri E, Emili R. Cancer Related Anemia: An Integrated Multitarget Approach and Lifestyle Interventions. Nutrients 2021;13:482. [PMID: 33535496 DOI: 10.3390/nu13020482] [Reference Citation Analysis]
12 Ramadass SK, Anantharaman NV, Subramanian S, Sivasubramanian S, Madhan B. Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells. Colloids Surf B Biointerfaces 2015;125:65-72. [PMID: 25437065 DOI: 10.1016/j.colsurfb.2014.11.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
13 Hasani P, Tehrani HS, Yaghmaei P, Roudbari NH. Effects of Camellia Sinensis Extract on Passive Avoidance Learning and Hippocampal Neurogenesis in Rats. Neurophysiology 2017;49:135-42. [DOI: 10.1007/s11062-017-9642-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Liu J, Zhong T, Yi P, Fan C, Zhang Z, Liang G, Xu Y, Fan Y. A new epigallocatechin gallate derivative isolated from Anhua dark tea sensitizes the chemosensitivity of gefitinib via the suppression of PI3K/mTOR and epithelial-mesenchymal transition. Fitoterapia 2020;143:104590. [PMID: 32272164 DOI: 10.1016/j.fitote.2020.104590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Cianciulli A, Porro C, Calvello R, Trotta T, Lofrumento DD, Panaro MA. Microglia Mediated Neuroinflammation: Focus on PI3K Modulation. Biomolecules 2020;10:E137. [PMID: 31947676 DOI: 10.3390/biom10010137] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 17.5] [Reference Citation Analysis]
16 Arkwright RT, Deshmukh R, Adapa N, Stevens R, Zonder E, Zhang Z, Farshi P, Ahmed RS, El-Banna HA, Chan TH, Dou QP. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics. Anticancer Agents Med Chem 2015;15:657-71. [PMID: 25511514 DOI: 10.2174/1871520615666141216145417] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
17 Singh P, Bast F. Screening of multi-targeted natural compounds for receptor tyrosine kinases inhibitors and biological evaluation on cancer cell lines, in silico and in vitro. Med Oncol 2015;32:233. [PMID: 26298529 DOI: 10.1007/s12032-015-0678-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
18 Bansal S, Vyas S, Bhattacharya S, Sharma M. Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties. Nat Prod Rep 2013;30:1438. [DOI: 10.1039/c3np70038k] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
19 Ren R, Yin S, Lai B, Ma L, Wen J, Zhang X, Lai F, Liu S, Li L. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity. Retrovirology 2018;15:49. [PMID: 30012153 DOI: 10.1186/s12977-018-0432-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
20 Peter B, Bosze S, Horvath R. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials. Eur Biophys J 2017;46:1-24. [PMID: 27313063 DOI: 10.1007/s00249-016-1141-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]